Survival outcomes of patients with resectable pancreatic cancer treated with upfront surgery versus neoadjuvant chemotherapy: A retrospective tertiary care center experience.

被引：0
|
作者：
Liu, Fang
Mirsky, Matthew
Wu, Sulin
Fu, Pingfu
Cao, Shufen
Shanahan, John
Kyasaram, Ravi Kumar
Jain, Prantesh
Hardacre, Jeffrey
Ammori, John Brian
Winter, Jordan Michael
Bajor, David Lawrence
机构：
[1] Univ Hosp, Cleveland, OH USA
[2] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Biostats & Epidemiol, Cleveland, OH 44106 USA
[5] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[6] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[8] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4623
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
    Qiancheng Hu
    Dan Wang
    Ye Chen
    Xiaofen Li
    Peng Cao
    Dan Cao
    Radiation Oncology, 14
  • [42] Neoadjuvant chemotherapy versus upfront surgery in early pancreatic cancer- are we any wiser in 2024?
    Maloney, Sarah
    Pavlakis, Nick
    Clarke, Stephen
    Samra, Jaswinder
    Mittal, Anubhav
    Sahni, Sumit
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 95 - 95
  • [43] Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery
    Barnes, Chad A.
    Chavez, Mariana, I
    Tsai, Susan
    Aldakkak, Mohammed
    George, Ben
    Ritch, Paul S.
    Dua, Kulwinder
    Clarke, Callisia N.
    Tolat, Parag
    Hagen, Catherine
    Hall, William A.
    Erickson, Beth A.
    Evans, Douglas B.
    Christians, Kathleen K.
    SURGERY, 2019, 166 (03) : 277 - 285
  • [44] Upfront Surgery versus Neoadjuvant Therapy for Resectable Pancreatic Cancer: Systematic Review and Bayesian Network Meta-analysis
    Bradley, Alison
    Van Der Meer, Robert
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [45] Neoadjuvant Treatment versus Upfront Surgery for Primary Resectable Pancreatic Cancer: An Update Meta-Analysis of Comparative Studies
    Roesel, R.
    Cristaudi, A.
    Deantonio, L.
    de Dosso, S.
    Berneardi, L.
    BRITISH JOURNAL OF SURGERY, 2023, 110 (SUPP 5)
  • [46] Upfront Surgery versus Neoadjuvant Therapy for Resectable Pancreatic Cancer: Systematic Review and Bayesian Network Meta-analysis
    Alison Bradley
    Robert Van Der Meer
    Scientific Reports, 9
  • [47] COMPARISON BETWEEN NEOADJUVANT CHEMOTHERAPY AND UPFRONT SURGERY FOR PATIENTS WITH RESECTABLE AND SYNCHRONOUS COLORECTAL CANCER HEPATIC METASTASES.
    Lee, J.
    Han, Y.
    Cho, M.
    Hur, H.
    Lee, K.
    Kim, N.
    Min, B.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E266 - E267
  • [48] Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
    Murakami, Masatoshi
    Fujimori, Nao
    Ohno, Akihisa
    Matsumoto, Kazuhide
    Teramatsu, Katsuhito
    Takamatsu, Yu
    Takeno, Ayumu
    Oono, Takamasa
    Abe, Toshiya
    Ideno, Noboru
    Ikenaga, Naoki
    Nakata, Kohei
    Nakamura, Masafumi
    Ishigami, Kousei
    Ogawa, Yoshihiro
    DISCOVER ONCOLOGY, 2022, 13 (01)
  • [49] Clinical characteristics and outcome of metaplastic breast cancer: A retrospective tertiary care center experience.
    Thapa, Bicky
    Arobelidze, Salome
    Jia, Xuefei
    Awada, Hassan
    Kewan, Tariq Zuheir
    Covut, Fahrettin
    Patel, Mita
    Daw, Hamed
    Spiro, Timothy Peter
    Haddad, Abdo S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study
    Masatoshi Murakami
    Nao Fujimori
    Akihisa Ohno
    Kazuhide Matsumoto
    Katsuhito Teramatsu
    Yu Takamatsu
    Ayumu Takeno
    Takamasa Oono
    Toshiya Abe
    Noboru Ideno
    Naoki Ikenaga
    Kohei Nakata
    Masafumi Nakamura
    Kousei Ishigami
    Yoshihiro Ogawa
    Discover Oncology, 13
12345